标题
Mitochondrial targets of metformin—Are they physiologically relevant?
作者
关键词
-
出版物
BIOFACTORS
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2019-07-25
DOI
10.1002/biof.1548
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Metformin directly targets the H3K27me3 demethylase KDM6A/UTX
- (2018) Elisabet Cuyàs et al. AGING CELL
- OCT1-Mediated Metformin Uptake Regulates Pancreatic Stellate Cell Activity
- (2018) Chunhua Wu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Metformin Targets Mitochondrial Glycerophosphate Dehydrogenase to Control Rate of Oxidative Phosphorylation and Growth of Thyroid CancerIn VitroandIn Vivo
- (2018) Shilpa Thakur et al. CLINICAL CANCER RESEARCH
- Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivo
- (2018) Anila K. Madiraju et al. NATURE MEDICINE
- Metformin selectively targets redox control of complex I energy transduction
- (2018) Amy R. Cameron et al. Redox Biology
- Molecular Mechanisms of Metformin for Diabetes and Cancer Treatment
- (2018) Min Li et al. Frontiers in Physiology
- Metformin, an Anti-diabetic Drug to Target Leukemia
- (2018) Giulia Biondani et al. Frontiers in Endocrinology
- Low metformin causes a more oxidized mitochondrial NADH/NAD redox state in hepatocytes and inhibits gluconeogenesis by a redox-independent mechanism
- (2018) Ahmed Alshawi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Metformin Mediates Protection againstLegionellaPneumonia through Activation of AMPK and Mitochondrial Reactive Oxygen Species
- (2017) Chiaki Kajiwara et al. JOURNAL OF IMMUNOLOGY
- Transporters Involved in Metformin Pharmacokinetics and Treatment Response
- (2017) Xiaomin Liang et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Pleiotropic Effects of Biguanides on Mitochondrial Reactive Oxygen Species Production
- (2017) Alena Pecinova et al. Oxidative Medicine and Cellular Longevity
- Phenformin has anti-tumorigenic effects in human ovarian cancer cells and in an orthotopic mouse model of serous ovarian cancer
- (2017) Amanda L. Jackson et al. Oncotarget
- Attenuation of CD4 + CD25 + Regulatory T Cells in the Tumor Microenvironment by Metformin, a Type 2 Diabetes Drug
- (2017) Yuki Kunisada et al. EBioMedicine
- Mitochondria-Targeted Analogues of Metformin Exhibit Enhanced Antiproliferative and Radiosensitizing Effects in Pancreatic Cancer Cells
- (2016) Gang Cheng et al. CANCER RESEARCH
- Environment Dictates Dependence on Mitochondrial Complex I for NAD+ and Aspartate Production and Determines Cancer Cell Sensitivity to Metformin
- (2016) Dan Y. Gui et al. Cell Metabolism
- Metformin Targets Central Carbon Metabolism and Reveals Mitochondrial Requirements in Human Cancers
- (2016) Xiaojing Liu et al. Cell Metabolism
- Metformin as a Tool to Target Aging
- (2016) Nir Barzilai et al. Cell Metabolism
- Are Metformin Doses Used in Murine Cancer Models Clinically Relevant?
- (2016) Navdeep S. Chandel et al. Cell Metabolism
- Metformin Pharmacokinetics in Mouse Tumors: Implications for Human Therapy
- (2016) Ryan J.O. Dowling et al. Cell Metabolism
- Anti-Inflammatory Effects of Metformin Irrespective of Diabetes StatusNovelty and Significance
- (2016) Amy R. Cameron et al. CIRCULATION RESEARCH
- Metformin Suppresses Diabetes-Accelerated Atherosclerosis via the Inhibition of Drp1-Mediated Mitochondrial Fission
- (2016) Qilong Wang et al. DIABETES
- Metformin-associated lactic acidosis: Current perspectives on causes and risk
- (2016) Ralph DeFronzo et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Mitochondrial Targeting of Metformin Enhances Its Activity against Pancreatic Cancer
- (2016) Stepana Boukalova et al. MOLECULAR CANCER THERAPEUTICS
- Metformin Decreases Reactive Oxygen Species, Enhances Osteogenic Properties of Adipose-Derived Multipotent Mesenchymal Stem Cells In Vitro, and Increases Bone Density In Vivo
- (2016) Krzysztof Marycz et al. Oxidative Medicine and Cellular Longevity
- Metformin prevents ischemia reperfusion-induced oxidative stress in the fatty liver by attenuation of reactive oxygen species formation
- (2015) Monika Cahova et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Effects of Metformin, Buformin, and Phenformin on the Post-Initiation Stage of Chemically Induced Mammary Carcinogenesis in the Rat
- (2015) Z. Zhu et al. Cancer Prevention Research
- Therapeutic Concentrations of Metformin: A Systematic Review
- (2015) Farshad Kajbaf et al. CLINICAL PHARMACOKINETICS
- Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota
- (2015) Kristoffer Forslund et al. NATURE
- Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria
- (2014) Hannah R. Bridges et al. BIOCHEMICAL JOURNAL
- Serine Deprivation Enhances Antineoplastic Activity of Biguanides
- (2014) S.-P. Gravel et al. CANCER RESEARCH
- Metformin: From Mechanisms of Action to Therapies
- (2014) Marc Foretz et al. Cell Metabolism
- The role of AMPK in controlling metabolism and mitochondrial biogenesis during exercise
- (2014) Katarina Marcinko et al. EXPERIMENTAL PHYSIOLOGY
- Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
- (2014) Anila K. Madiraju et al. NATURE
- Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis
- (2014) William W Wheaton et al. eLife
- Metformin Decreases Glucose Oxidation and Increases the Dependency of Prostate Cancer Cells on Reductive Glutamine Metabolism
- (2013) S.-M. Fendt et al. CANCER RESEARCH
- Potential applications for biguanides in oncology
- (2013) Michael Pollak JOURNAL OF CLINICAL INVESTIGATION
- Mitochondrial energetic and AKT status mediate metabolic effects and apoptosis of metformin in human leukemic cells
- (2013) S Scotland et al. LEUKEMIA
- Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP
- (2013) Russell A. Miller et al. NATURE
- The function and the role of the mitochondrial glycerol-3-phosphate dehydrogenase in mammalian tissues
- (2012) Tomáš Mráček et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Clinical Pharmacokinetics of Metformin
- (2011) Garry G. Graham et al. CLINICAL PHARMACOKINETICS
- Cellular and molecular mechanisms of metformin: an overview
- (2011) Benoit Viollet et al. CLINICAL SCIENCE
- Innate immunity, insulin resistance and type 2 diabetes
- (2011) J. M. Fernández-Real et al. DIABETOLOGIA
- Metformin reduces intracellular reactive oxygen species levels by upregulating expression of the antioxidant thioredoxin via the AMPK-FOXO3 pathway
- (2010) Xinguo Hou et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis
- (2010) A. DeCensi et al. Cancer Prevention Research
- Mammalian Target of Rapamycin (mTOR): Conducting the Cellular Signaling Symphony
- (2010) Kathryn G. Foster et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state
- (2010) Marc Foretz et al. JOURNAL OF CLINICAL INVESTIGATION
- New Users of Metformin Are at Low Risk of Incident Cancer: A cohort study among people with type 2 diabetes
- (2009) G. Libby et al. DIABETES CARE
- Biguanide-induced mitochondrial dysfunction yields increased lactate production and cytotoxicity of aerobically-poised HepG2 cells and human hepatocytes in vitro
- (2008) James A. Dykens et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Dose translation from animal to human studies revisited
- (2007) Shannon Reagan-Shaw et al. FASEB JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More